Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

InnoCan Pharma

INNPFOTCQB

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.1259

At close: Jan 14, 1:14 PM EDT

$0.2410

0.1291.36%

After Hours: Sep 21, 9:10 AM EDT

InnoCan Pharma (INNPF) Forecast

News

Earnings InnoCan Pharma (INNPF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for InnoCan Pharma (OTC:INNPF) Stock

InnoCan Pharma Stock (OTC: INNPF)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, November 21, 2024

Cannabinoid Leader Innocan Pharma's Q3: 174% YoY Revenue Growth
Patricio Liddle

Tuesday, May 28, 2024

CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark
Patricio Liddle

Tuesday, April 23, 2024

This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain
Jelena Martinovic

Tuesday, April 02, 2024

534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations
Patricio Liddle

Tuesday, February 13, 2024

CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval
Jelena Martinovic

Monday, October 23, 2023

More Cannabis Funding For FDA And Product Expansion: How This Pharma Tech Company Is Doing It
Jelena Martinovic

Thursday, September 21, 2023

CBD-Focused Pharma Co. Seeks Funding To Revolutionize Healthcare
Jelena Martinovic

Monday, August 28, 2023

Innocan Pharma's Q2 2023 Reports Gross Profit Growth Driven By Robust Subsidiary Sales
Nicolás Jose Rodriguez

Friday, August 25, 2023

Cannabis Stock Gainers And Losers From August 25, 2023
Benzinga Insights

Monday, August 21, 2023

Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
Benzinga Insights

Thursday, August 17, 2023

Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
Benzinga Insights

Monday, August 14, 2023

Cannabis Stock Gainers And Losers From August 14, 2023
Benzinga Insights

Friday, August 11, 2023

Cannabis Stock Gainers And Losers From August 11, 2023
Benzinga Insights

Friday, August 04, 2023

Innocan Pharma Secures $1.4M Via Private Placement
Vuk Zdinjak

Tuesday, July 25, 2023

Innocan Pharma To Secure Up To $3M Via Private Placement Of Units At A 9% Prime Above Share Price
Vuk Zdinjak

Friday, July 21, 2023

Cannabis Stock Movers For July 21, 2023
Benzinga Insights

Thursday, June 01, 2023

Innocan Pharma Q1 Revenue Grows 500% YoY, Here Is What You Need To Know
Vuk Zdinjak

Wednesday, April 19, 2023

Innocan Pharma FY22 Revenue Grows 1205% To $2.6M, Here Is What You Need To Know
Vuk Zdinjak

Tuesday, February 21, 2023

Can Liposomal CBD Injection Help Dogs With Polyarthritis? Innocan Pharma Reports Clinical Success
Vuk Zdinjak

Tuesday, November 29, 2022

Innocan Pharma Q3 Revenue Grows 700% YoY, Here Is What You Need To Know
Vuk Zdinjak

Tuesday, November 02, 2021

4 CBD Stocks in the Canadian Capital Market
Josh Horowitz - Sponsored

Tuesday, December 01, 2020

Innocan Pharma's CBD Treatments Progress Into The Next Stage
Josh Horowitz

Monday, June 03, 2019

Nabis Holdings Acquires 49% Stake In Israel-Based Cannova Medical
Alex Oleinic

Sunday, April 07, 2019

This Week's Cannabis News: The FDA And CBD, The STATES Act, Cresco And Origin House, Europe And High Times
Javier Hasse

Thursday, April 04, 2019

Nabis Execs Talks $26M Raise: 'It Takes A Unique Product Offering, Solid Development, Branding And Distribution'
Javier Hasse

Sunday, February 03, 2019

Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week
Javier Hasse

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved